Biogen (BIIB) Net Margin (2009 - 2026)
Biogen (BIIB) posted quarterly Net Margin of 3.56% for Q2 2026, down 2043.0% year-over-year from 0.18% in Q2 2025, and down 72.36% quarter-over-quarter from 12.89% in Q1 2026.
Biogen (BIIB) Net Margin (2009 - 2026) Analysis & Trends
Biogen's Net Margin history runs 18 years deep, the most recent figure standing at 3.56% for Q2 2026.
- In Q2 2026, Net Margin fell 2043.0% year-over-year to 3.56%; the TTM figure through Jun 2026 stood at 8.32% (down 699.0% YoY), while the FY2025 annual figure was 13.07%, down 380.0% from the prior year.
- Net Margin for Q2 2026 stood at 3.56%, down from 12.89% in the prior quarter.
- The five-year high for Net Margin was 45.24% in Q3 2022, with the low at 2.7% in Q3 2023.
- The 5-year median for Net Margin is 15.75% (2023), against an average of 16.55%.
- The sharpest annual moves came in 2022 and 2023: Net Margin surged 3383 bps in 2022, then plunged 4794 bps in 2023.
- Biogen's Net Margin stood at 21.6% in 2022, then sank by 52 bps to 10.43% in 2023, then gained by 4 bps to 10.86% in 2024, then plunged by 120 bps to 2.15% in 2025, then surged by 266 bps to 3.56% in 2026.
- Business Quant data shows BIIB's Net Margin at 3.56% in Q2 2026, 12.89% in Q1 2026, and 2.15% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.37 Bn | 632.61 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 469.65 Bn | 463.08 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 376.13 Bn | 368.99 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 303.28 Bn | 295.59 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 258.06 Bn | 253.16 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 236.35 Bn | 222.36 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 182.15 Bn | 178.97 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 159.57 Bn | 147.87 Bn | 10.94 Bn | -1.58% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 5.17% |
| 10 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 3.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.56% |
| Mar 31, 2026 | 12.89% |
| Dec 31, 2025 | -2.15% |
| Sep 30, 2025 | 18.40% |
| Jun 30, 2025 | 24.00% |
| Mar 31, 2025 | 9.89% |
| Dec 31, 2024 | 10.86% |
| Sep 30, 2024 | 15.76% |
| Jun 30, 2024 | 23.68% |
| Mar 31, 2024 | 17.18% |
| Dec 31, 2023 | 10.43% |
| Sep 30, 2023 | -2.70% |
| Jun 30, 2023 | 24.16% |
| Mar 31, 2023 | 15.74% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | 45.24% |
| Jun 30, 2022 | 40.66% |
| Mar 31, 2022 | 8.76% |
| Dec 31, 2021 | -1.40% |
| Sep 30, 2021 | 11.41% |